This study is in progress, not accepting new patients
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
a study on Inflammatory Bowel Disease
Ulcerative Colitis open-label long term treatment Colitis Ulcer Colitis, Ulcerative Tofacitinib CP-690,550 CP-690,550 5 mg BID CP-690,550 10 mg BID
Lead Scientist at UCSF
- Uma Mahadevan
Dr. Mahadevan completed a medical degree at the State University of New York in Brooklyn. She completed residency in internal medicine at Mount Sinai Medical Center in New York, a fellowship in gastroenterology at the University of California, San Francisco (UCSF) and a fellowship in inflammatory bowel disease (IBD) at the Mayo Clinic in Rochester, Minnesota.
- in progress, not accepting new patients
- Start Date
- Completion Date
- To obtain contact information for a study center near you, click here.
- Phase 3
- Study Type
- Last Updated